FDA 483 - Protherics UK Limited - June 23, 2022

An FDA inspection of Protherics UK Ltd. in Llandysul, UK, revealed significant deficiencies in quality control testing procedures, facility qualification for aseptic operations, and environmental monitoring systems. These issues indicate potential risks to product quality and sterility assurance. The firm needs to address these systemic problems to ensure compliance with regulatory standards.